Predictors of Resistance in Pediatric Helicobacter pylori Infection
Pathogens · 05.06.2026 · 15 (6) · 608
DOI: 10.3390/pathogens15060608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 05.06.2026. Verfasst von Kim Ruiz-Arellanos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Helicobacter pylori (H. pylori) antimicrobial resistance is a key driver of eradication failure in children and adults. Recognizing factors associated with H. pylori antimicrobial resistance may help identify individuals at risk for treatment failure and tailor management. We conducted a retrospective cohort study of patients with H. pylori-positive gastric biopsy culture and available antimicrobial susceptibility data at a large pediatric tertiary care center between 2020 and 2025. Descriptive statistics and logistic regression models were used to assess associations among demographic characteristics, prior treatment history, and antimicrobial resistance. Of 174 patients (56.1% male, median 14 years), 50.3% were resistant to at least one antimicrobial. Resistance rates included metronidazole (28.3%), clarithromycin (18.5%), rifampin (12.7%), fluoroquinolones (11.6%), amoxicillin (4%), and tetracycline (0.6%). The multidrug resistance rate was 17.3%. Prior H. pylori treatment was the most consistent predictor of antimicrobial resistance on both bivariate and multivariable analyses. Race was independently associated with metronidazole resistance, with Black patients exhibiting the highest rates and significantly greater odds compared to White patients. Hispanic ethnicity was also independently associated with increased odds of metronidazole resistance. Careful consideration of prior treatment history, race, and ethnicity is warranted when managing pediatric H. pylori infection, given their association with increased antimicrobial resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.
- Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA 02115, USA.
ORCID-Profile: Kim Ruiz-Arellanos, Silvana Bonilla
Zitieren
APA
Ruiz-Arellanos, K., Cardenas-Fernández, M. C., & Bonilla, S. (2026). Predictors of Resistance in Pediatric Helicobacter pylori Infection. Pathogens, 15(6), 608. https://doi.org/10.3390/pathogens15060608
Vancouver
Ruiz-Arellanos K, Cardenas-Fernández MC, Bonilla S. Predictors of Resistance in Pediatric Helicobacter pylori Infection. Pathogens. 2026;15(6):608. doi:10.3390/pathogens15060608
BibTeX
@article{RuizArellanos2026,
author = {Ruiz-Arellanos, Kim and Cardenas-Fernández, Maria Camila and Bonilla, Silvana},
title = {Predictors of Resistance in Pediatric Helicobacter pylori Infection},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {6},
pages = {608},
doi = {10.3390/pathogens15060608}
}
EUVIMED